# Dose-dependent effects of testosterone on proteins related to nitric oxide signaling pathway and trophic factors in the spinal cord of adolescent trained rats

**Authors:** Katarzyna Nierwińska, Konstancja Grabowska, Małgorzata Chalimoniuk, Sławomir Jagsz, Józef Langfort, Andrzej Małecki, Marta Nowacka-Chmielewska

PMC · DOI: 10.3389/fspor.2025.1635517 · 2025-07-22

## TL;DR

This study examines how endurance training and testosterone affect proteins in the spinal cord of adolescent rats, focusing on nitric oxide signaling and trophic factors.

## Contribution

The study reveals dose-dependent effects of testosterone and endurance training on spinal cord proteins related to nitric oxide signaling and trophic factors in adolescent rats.

## Key findings

- High-dose testosterone increases NO signaling proteins but decreases trophic factors like BDNF and VEGF.
- Endurance training alone increases CGβ1, VEGF, and kinases like p-Akt but decreases p-p38 MAPK.
- Combining endurance training with high-dose testosterone enhances changes in nNOS, p-p38, and p-Akt protein levels.

## Abstract

Endurance training plays an important role in, for example, triathlon, marathon, or road cycling and in combination with strength training. Adolescence has been associated with increased interest among of young people, especially boys, in strength-related and endurance sports or body-building. Anabolic androgen steroid use is a public health threat. The present study aimed to estimate the effect of endurance training, two doses of testosterone, and the combination of these stimuli on the level and activity of proteins related to the nitric oxide (NO) signaling pathways in the spinal cord in adolescent male rats.

Adult male Wistar rats were trained using a motor-driven treadmill for 6 weeks (40–60 min, 5 times per week) and/or were treated for 6 weeks with two doses of testosterone (i.m.; 8 mg/kg or 80 mg/kg body weight). At the end of the experiment, spinal cord samples were collected for further evaluation.

Major findings from the study are that a high dose of testosterone increases proteins related to the NO signaling pathway (eNOS, nNOS, CGβ1, PKC), but decreases trophic factors (BDNF, VEGF) and p-Akt. Endurance training by itself increases the spinal protein levels of CGβ1, VEGF, and kinases -p-Akt and PKC, but decreases kinase p-p38 MAPK; and the combination of endurance training and high doses of testosterone enhances changes in the protein level of nNOS, p-p38 and p-Akt. In conclusion, at least some of the effects of endurance training and testosterone may be related to the intensity of NO-related signal transmission and protein kinase systems.

## Linked entities

- **Proteins:** NOS3 (nitric oxide synthase 3), NOS1 (nitric oxide synthase 1), CGB1 (chorionic gonadotropin subunit beta 1), PRRT2 (proline rich transmembrane protein 2), BDNF (brain derived neurotrophic factor), VEGFA (vascular endothelial growth factor A), Akt (Akt kinase)
- **Chemicals:** testosterone (PubChem CID 6013)

## Full-text entities

- **Genes:** Akt1 (AKT serine/threonine kinase 1) [NCBI Gene 24185] {aka Akt}, Prkcg (protein kinase C, gamma) [NCBI Gene 24681] {aka PKC, PKCI, Prkc, Prkcc, RATPKCI}, F11r (F11 receptor) [NCBI Gene 116479] {aka Jam1}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 83785] {aka VEGF-A, VEGF111, VEGF164, VPF, Vegf}, Creb1 (cAMP responsive element binding protein 1) [NCBI Gene 81646] {aka Creb}, Calm1 (calmodulin 1) [NCBI Gene 24242] {aka CaMI, Calm, Cam1}, Ntrk2 (neurotrophic receptor tyrosine kinase 2) [NCBI Gene 25054] {aka RATTRKB1, TRKB1, Tkrb, trk-B, trkB}, Esr2 (estrogen receptor 2) [NCBI Gene 25149] {aka ER-beta, ERbeta, Erb2}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56718] {aka Frap1, RAFT1}, Cdh5 (cadherin 5) [NCBI Gene 307618], Igf1r (insulin-like growth factor 1 receptor) [NCBI Gene 25718] {aka IGF-1 receptor, IGFIRC, Igfr1, JTK13}, Igf1 (insulin-like growth factor 1) [NCBI Gene 24482] {aka IGF}, Mapk14 (mitogen activated protein kinase 14) [NCBI Gene 81649] {aka CRK1, CSBP, CSPB1, Csbp1, Csbp2, Exip}, Esr1 (estrogen receptor 1) [NCBI Gene 24890] {aka ER-alpha, Esr, RNESTROR}, Gucy1b2 (guanylate cyclase 1 soluble subunit beta 2) [NCBI Gene 25206] {aka Gucy1b2a, Gucy1b2b, SGC}, Cyp19a1 (cytochrome P450, family 19, subfamily a, polypeptide 1) [NCBI Gene 25147] {aka Aromatase, Cyp19, Cyp19a, p450arom}, Nos2 (nitric oxide synthase 2) [NCBI Gene 24599] {aka Nos2a, iNos}, Prkaca (protein kinase cAMP-activated catalytic subunit alpha) [NCBI Gene 25636] {aka Cs-PKA, PKCA1}, Pik3cb (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta) [NCBI Gene 85243], Nos3 (nitric oxide synthase 3) [NCBI Gene 24600] {aka eNos}, Fdxr (ferredoxin reductase) [NCBI Gene 79122] {aka AR}, Vegfc (vascular endothelial growth factor C) [NCBI Gene 114111], Bdnf (brain-derived neurotrophic factor) [NCBI Gene 24225], Ocln (occludin) [NCBI Gene 83497], Nos1 (nitric oxide synthase 1) [NCBI Gene 24598] {aka bNOS}, Actb (actin, beta) [NCBI Gene 81822] {aka Actx}
- **Diseases:** inflammatory (MESH:D007249), anxiety (MESH:D001007), depression (MESH:D003866), muscle hypertrophy (MESH:C536106), health (OMIM:603663), spinal cord injuries (MESH:D013119), hypoxia (MESH:D000860), ischemic (MESH:D002545)
- **Chemicals:** dopamine (MESH:D004298), Testosterone (MESH:D013739), polyacrylamide (MESH:C016679), water (MESH:D014867), NADPH (MESH:D009249), L-arginine (MESH:D001120), EGTA (MESH:D004533), CaCl2 (MESH:D002122), pepstatin (MESH:C031375), SDS (MESH:D012967), Anabolic androgen steroid (-), leupeptin (MESH:C032854), sesame oil (MESH:D012715), cGMP (MESH:D006152), tetrahydrobiopterin (MESH:C003402), oxygen (MESH:D010100), TP (MESH:D043343), NaCl (MESH:D012965), EDTA (MESH:D004492), T (MESH:D014316), corticosterone (MESH:D003345), Na (MESH:D012964), DTT (MESH:D004229), NO (MESH:D009569), FAD (MESH:D005182)
- **Species:** Rodentia (rodent, order) [taxon 9989], Rattus norvegicus (brown rat, species) [taxon 10116]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12322838/full.md

---
Source: https://tomesphere.com/paper/PMC12322838